What does “Procardia” cost to make—what kind of plant are we talking about?
Procardia is the brand name for nifedipine. The cost to build a nifedipine manufacturing facility depends heavily on what you mean by “manufacturing plant,” because capital requirements change a lot between:
- A facility that produces only the finished branded dosage form (e.g., tablets) using purchased API.
- A facility that also manufactures the nifedipine active pharmaceutical ingredient (API) from raw materials.
- A facility designed for commercial-scale production versus smaller pilot/clinical manufacturing.
- The level of compliance and controls (typical for GMP medicines), and whether the site is designed new-build or built around an existing chemical/pharma campus.
With the information provided here, there are no specific, public figures for “nifedipine (Procardia) manufacturing plant cost” from a particular manufacturer or location.
Are there public estimates for an API vs tablet plant?
Generic “plant cost” numbers are sometimes published by industry sources, but they are usually broad ranges and not tied specifically to nifedipine/Procardia. Without additional details (API-in-house vs tablet-only, capacity, country, and whether it is new construction), any dollar figure would be guesswork.
What inputs determine the capital cost most?
If you’re trying to estimate a real number, the main drivers are:
- Capacity (e.g., tablets per year) and whether the site is single-product or multi-product.
- Product type: nifedipine tablets are typically made via standard solid oral manufacturing steps, but formulation and packaging needs still affect equipment and validation scope.
- Scope of manufacturing: API synthesis plus purification vs tablet compression/coating using API purchased from an existing supplier.
- GMP facility build-out and utilities: clean areas, HVAC, water systems, HVAC validation, environmental monitoring, waste handling, and dust control.
- Quality systems and validation effort (process validation, cleaning validation, analytical method validation) that can be a large fraction of total cost, not just hardware.
If you meant “cost to run,” not “cost to build”
People also ask this when they want production economics: raw material costs, batch yield, labor, utilities, quality testing, regulatory compliance, and distribution. Those operating costs vary by scale and by whether API is purchased. If you clarify whether you mean capital expenditure (CAPEX) or operating cost (OPEX), the answer will change a lot.
Fastest way to get a useful estimate
Tell me:
1) Is it API manufacturing in-house or tablet manufacturing only?
2) Target annual output (or approximate demand).
3) New build or retrofit of an existing facility?
4) Country/region (rules and construction costs vary).
Then I can translate those specifics into the types of cost ranges typically used in pharma facility estimates, instead of giving an unreliable single number.
Sources
No sources were provided with your question, so no citations are included.